葛根素注射液治疗不稳定性心绞痛疗效分析

目的　观察葛根素注射液治疗不稳定性心绞痛 (UA)的临床疗效。方法　将 6 8例不稳定性心绞痛患者随机分为治疗组和对照组。对照组 :服用肠溶阿司匹林 10 0～ 30 0mg/d ,10 %葡萄糖 5 0 0ml加 10 %氯化钾 15ml+2 5 %硫酸镁 10ml加普通胰岛素 12U ;治疗组 :在上述基础上加用葛根素注射液 4 0 0mg加 5 %葡萄糖 4 0 0ml。两组均静脉滴注 ,1次 /d ,15d为 1疗程。结果　心绞痛缓解情况 :治疗组总有效率为 85 .3% ,对照组为 6 1.8%(P <0 .0 5 ) ;心电图改善情况 :治疗组总有效率为 82 .4 % ,对照组为 5 5 .9% (P <0 .0 5 )。结论　在常规治疗基础上加用葛根素注射液 ,能有效地控制心绞痛发作。     

低分子肝素对不稳定型心绞痛病理生理干预作用的研究

目的:观察低分子肝素(LMWH)对不稳定型心绞痛((UAP)的临床症状、心电图、血脂以及内皮素(ET)的影响。方法:前瞻性地将84例UAP患者随机分为两组:对照组使用硝酸甘油、倍他乐克、阿司匹林等药物;治疗组(LMWH组)在上述治疗基础上加用LMWH(速避凝)。治疗前后调查临床症状以及心电图改变,抽血测定血脂、红细胞压积、血小板及内皮素水平的变化。结果:两组治疗后,患者心绞痛发作次数、持续时间以及硝酸甘油的用量明显减少,心电图明显改善,且LMWH组优于对照组(P<0.05)。LMWH治疗后,患者HCT、TC、TG及ET较治疗前明显降低(P<0.05)。对照组血浆ET水平无变化。结论:LMWH对UAP患者不仅具有抗凝抗栓作用,而且可以降低血液粘度、保护血管内皮细胞,纠正脂类代谢紊乱状态,     

下腰椎失稳合并椎管狭窄症的手术治疗

目的：观察下腰椎失稳合并椎管狭窄症患者经椎弓根螺钉系统及椎体融合器治疗的效果。方法：采用后路减压，椎弓根螺钉系统内固定，椎体间融合器BAK融合。结果：术后随访1年一4年3个月(平均2年4个月)，椎体间骨性融合率1年89．6％，2年2个月100％，临床症状消失满意率92％。结论：采用椎管减压、椎弓根螺钉系统加椎间融合器固定，可使滑脱失稳的椎体部分或全部复位，保证脊柱骨性融合，达到脊柱稳定、解除症状的目的。     

Quality of life on enalapril after acute myocardial infarction

Quality of life was assessed 4–6 months after an acutemyocardial infarction in a randomized double-blind study ofenalapril versus placebo. Quality of life was evaluated usingthe Nottingham Health Profile (NHP), the Physical Symptoms DistressIndex (PSDI), the Work Performance Scale (WPS) and the LifeSatisfaction Index (LSI). The study comprised 36 women (aged46–85 years, mean 68) and 96 males (aged 39–81 years,mean 62). Quality of life did not differ significantly between patientstreated with enalapril versus placebo. The scores were (enalaprilvs placebo, mean± SE): average NHP 15.4 ± 2.3vs 17.1 ± 2.3; PSDI 9.5± 1.0 vs 10.8 ±0.9; WPS 19.8 ± 2.0 vs 19.4 ± 1.4; LSI 24.1 ±1.0 vs 22.5 ±1.4. Men reported a better quality of lifethan women on most assessments, and non-smokers and ex-smokersbetter than smokers. Patients with moderate or severe anginapectoris had a worse quality of life measured by PSDI and NHPthan patients with minimal or no angina pectoris. Patients withcongestive heart failure had a higher PSDI than those without(13.6 ± 1.7 vs 9.4 ± 0.7, P<0.05), while nosignificant differences were observed in the NHP scores. In conclusion, quality of life was similar in enalapril andplacebo- treated patients after an acute myocardial infarction.However, it was reduced in patients with angina pectoris orheart failure and in those who continued smoking.     

葛根素注射液治疗不稳定型心绞痛疗效观察

目的:评价葛根素对不稳定型心绞痛的临床疗效。方法:85例不稳定型心绞痛患者随机分为2组,均常规口服消心痛,同时治疗组葛根素注射液400mg/d,对照组极化液500mL/d。结果:2周后心绞痛缓解,总有效率对照组为70%,治疗组为88.9%,差别不显著(P>0.05);心电图疗效比较,治疗组心肌缺血改善的总有效率71.1%,对照组40%,差别显著(P<0.05);血液流变学比较,治疗组全血粘度、血浆粘度及血小板聚集率均有明显改善(P<0.05),而对照组无此作用。结论:葛根素能有效地改善不稳定型心绞痛患者的症状,抗心肌缺血,降低血液粘度。     

红花注射液治疗冠心病心绞痛、心肌缺血临床观察

目的:观察红花注射液治疗冠心病心绞痛、心肌缺血的临床疗效。方法:选择126例冠心病心绞痛、心肌缺血的病例,分红花组及丹参组,疗程两周,详细记录治疗前后的临床表现、心电图、血糖、血脂、血液流变学检查的变化。结果:红花、丹参均可明显改善冠心病心肌缺血相应的临床症状和心电图改变,以红花较显著。红花还有降血糖、血脂作用,显著改善血液流变指标。结论:红花注射液是治疗冠心病心绞痛、心肌缺血的理想药物。     

低分子肝素钙联合辛伐他汀治疗不稳定型心绞痛疗效观察

目的探讨低分子肝素联合辛伐他汀治疗不稳定型心绞痛的疗效。方法将100例不稳定型心绞痛患者随机分为对照组50例和观察组50例。对照组仅采取常规治疗（硝酸酯类、β-受体阻滞剂、钙拮抗剂、阿司匹林等），观察组在常规治疗的基础上加用低分子肝素和辛伐他汀，观察比较各组的疗效。结果观察组总有效率为90．0％，对照组总有效率为60．0％，两组疗效比较差异有显著性意义（P〈0．05）。结论低分子肝素联合辛伐他汀治疗不稳定型心绞痛取得满意的疗效。     

对急性冠状动脉综合征的新认识和治疗对策

近几年来，由于基础实验研究的迅速发展，对急性冠状动脉综合征(ACS)的认识和治疗取得了重大进展。作者就ACS分子生物学和细胞学基础、不稳定斑块的治疗对策、ACS的危险分层及治疗方法作一综述。     

Clinical significance of 201Tl reverse redistribution in patients with aorto-coronary bypass surgery

Detection of myocardial ischemia by the stress thallium scan has traditionally been performed using transient defect analysis on exercise, followed by redistribution studies. Worsening of the ²⁰¹Tl myocardial image from exercise to redistribution is referred to as reverse redistribution. In this study, we found reverse redistribution in 10 (21%) of 48 angina pectoris patients who had undergone aortocoronary bypass surgery. The clinical significance of this phenomenon in these patients was investigated in relation to angiographic and surgical findings. Reverse redistribution was found to occur in regions which were supplied by bypass grafts. These areas showed increased coronary blood flow and rapid thallium washout. Our results indicate that a perfusion defect in the bypass region of the redistribution image might be caused by relatively rapid washout in the bypass graft region compared to the adjacent normal myocardium. These results should be considered in the clinical interpretation of stress thallium scans.     

低分子肝素治疗不稳定性心绞痛临床观察

目的:观察低分子肝素治疗不稳定性心绞痛病人的疗效。方法:不稳定性心绞痛病人80例,随机分为两组:治疗组(40例),给予阿司匹林和抗心绞痛常规治疗下,加低分子肝素5000U,每12h一次,连用14d,对照组(40例),给予阿司匹林和抗心绞痛常规治疗。结果:治疗组与对照组在改善心绞痛症状及心电图表现方面总有效率分别为87.5％、70.0％(P<0.05),两组均未发生心脏事件。结论:低分子肝素是一种有效安全的治疗不稳定性心绞痛的药物。